Astellas Gets Europe Okay For AML Drug Xospata

Pulls Further Ahead Of Daiichi Sankyo's Rival FLT3 Inhibitor

 
• By Kevin Grogan
  
Check list
Astellas ticks off a third major approval for Xospata • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category